FDA Approved: TICAGRELOR — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ticagrelor from Mylan Pharmaceuticals (ANDA 208597), allowing the generic ticagrelor product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

SUPPL AP for TICAGRELOR (TICAGRELOR)